Box score
Bambusa Therapeutics, Inc.
Reported $53.3M sold in a new Form D filed February 26, 2025 (Boston, Massachusetts).
- Biggest raise
- $53.3M filed Feb 26, 2025
- League
- Bio & Health Biotechnology
- Based in
- Boston, Massachusetts
- Season rank
- #68 of 1,311 in the Bio & Health League; #432 of 12,397 overall (2025)
- Incorporated
- 2024
- Entity
- Corporation
Form D filings since 2024 3
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2025-02-26 | New notice | $53.3M | $88.9M | SEC |
| 2025-01-08 | New notice | $9M | $9M | SEC |
| 2025-01-08 | New notice | $5.1M | $5.1M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 2044950.
Similar raises, 2025
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Imbria Pharmaceuticals, Inc. | Bio & Health | $59.2M |
| 2 | Dewpoint Therapeutics, Inc. | Bio & Health | $59.1M |
| 3 | Antares Therapeutics, Inc. rookie | Bio & Health | $40M |
| 4 | MarvelBiome, Inc. | Bio & Health | $39.6M |
| 5 | Mediar Therapeutics, Inc. | Bio & Health | $37.8M |
| 6 | Normunity Holding Company, LLC | Bio & Health | $37.5M |